Interestingly, circRNA SCAR alleviates high fat diet-induced cirrhosis in mice, suggesting that the manipulation of circRNA SCAR expression may be applicable to therapeutic strategies of NASH. This evidence concerns the gene RPS4X and metabolic dysfunction-associated steatohepatitis.